Marktprognose für Transfektionsreagenzien und -geräte im asiatisch-pazifischen Raum bis 2030 – Regionale Analyse – nach Produkt (Reagenzien und Instrumente), Methode (virale Methoden, nicht-virale Methoden und Hybridmethoden), Anwendung (biomedizinische Forschung, Proteinproduktion und Therapeutikaverabreichung) und Endnutzer (Akademien und Forschungsinstitute sowie Pharma- und Biotechnologieunternehmen)

BMIRE00030389 | Pages: 122 | Medical Device | Jul 2024 | Type: Regional | Status: Published
Der Markt für Transfektionsreagenzien und -geräte im asiatisch-pazifischen Raum wurde im Jahr 2022 auf 222,23 Millionen US-Dollar geschätzt und soll bis 2030 414,29 Millionen US-Dollar erreichen; es wird geschätzt, dass er von 2022 bis 2030 eine durchschnittliche jährliche Wachstumsrate von 8,1 % verzeichnen wird.

Wachsende wirtschaftliche Belastung durch Krebs beflügelt den Markt für Transfektionsreagenzien und -geräte im asiatisch-pazifischen Raum

Laut der Weltgesundheitsorganisation (WHO) ist Krebs eine der häufigsten Todesursachen weltweit und war im Jahr 2020 für etwa 10 Millionen Todesfälle verantwortlich. Laut der Internationalen Agentur für Krebsforschung wird die globale Krebsbelastung bis 2040 wahrscheinlich um 30,2 Millionen zusätzliche Fälle zunehmen. Laut der Brustkrebsorganisation sind etwa 5–10 % der Brustkrebsfälle weltweit erblich bedingt und werden durch abnormale Gene verursacht, die von Generation zu Generation weitergegeben werden. Laut dem Artikel „Lifestyle, Genetic Risk and Incidence of Cancer“, der 2023 im International Journal of Epidemiology veröffentlicht wurde, sind fast 33 % der auftretenden Krebserkrankungen erblich bedingt, und das Risiko genetischer Mutationen ist bei dieser Krankheit hoch. Daher entscheiden sich die Menschen für eine genetische Profilierung zur Früherkennung und personalisierten Behandlung von erblich bedingten Krebsfällen. BRCA1 und BRCA2 werden manchmal als Tumorsuppressorgene bezeichnet. Menschen, die die schädlichen Varianten eines dieser Gene erben, haben ein höheres Risiko für verschiedene Krebsarten, insbesondere Brust- und Eierstockkrebs. Diese Menschen neigen auch dazu, in jüngeren Jahren an Krebs zu erkranken als Menschen, die keine Variationen in den genannten Genen aufweisen. Studien, die sich auf die Verarbeitung von Nukleinsäure durch Krebszellen konzentrieren, werden wahrscheinlich dazu beitragen, den Krebsstoffwechsel zu verstehen. DNA wird typischerweise in ein virales oder nicht-virales Partikel verpackt, um in die zu transfizierende Zelle übertragen zu werden. Der Gentransfer wurde als neuer Ansatz vorgeschlagen, um die Wirksamkeit von Antitumormedikamenten bei der Behandlung hartnäckiger oder metastasierter Krebserkrankungen zu verbessern. Die Kombination von Gentherapie und Medikamenten (ähnliche Therapie) soll die antiproliferativen Effekte klassischer Behandlungen unter anderem bei Lungen-, Dickdarm-, Bauchspeicheldrüsen-, Blasen- und Brustkrebs verstärken. Somit stärkt die zunehmende wirtschaftliche Belastung durch Krebs den Markt für Transfektionsreagenzien und -geräte im asiatisch-pazifischen Raum.

Marktübersicht für Transfektionsreagenzien und -geräte im asiatisch-pazifischen Raum

Die Region Asien-Pazifik ist in China, Japan, Indien, Südkorea, Australien und den Rest des asiatisch-pazifischen Raums unterteilt. China hält im Jahr 2022 den größten Marktanteil. Länder im asiatisch-pazifischen Raum wie China, Indien, Singapur und weitere verfügen über ein gut etabliertes Gesundheitssystem sowie eine schnell wachsende Pharma- und Medizinindustrie. Diese Länder verfügen über viele Gesundheitseinrichtungen, die Krebspatienten behandeln und betreuen. Einer NIH-Studie zufolge stieg die Zahl der jährlichen Patienteneinweisungen in Krebskrankenhäuser in China im Zeitraum 2010–2020 von 1,10 Millionen auf 3,24 Millionen. Laut einer 2023 im Journal of the American Medical Association veröffentlichten Studie liegt die Prävalenz chronischer Nierenerkrankungen (CKD) bei Menschen ab 18 Jahren in Festlandchina bei 8,2 %. Darüber hinaus zeigen die neuesten Daten der International Agency for Research on Cancer (IARC), dass die geschätzte altersstandardisierte Rate (ASR) für Magenkrebs in China 21 pro 100.000 beträgt und die Rohrate 33,06 beträgt; für Bauchspeicheldrüsenkrebs beträgt die ASR 5 pro 100.000 mit einer Rohrate von 8,6. Der gleichen Quelle zufolge betrug die geschätzte Zahl der Neuerkrankungen an Magenkrebs und Bauchspeicheldrüsenkrebs bei Menschen im Alter von 0–74 Jahren im Jahr 2020 (für beide Geschlechter) 478.508 bzw. 124.994. Somit treibt die hohe Belastung durch chronische Krankheiten die Nachfrage nach CGTs in China an, was wiederum das Wachstum des Marktes für Transfektionsreagenzien und -geräte ankurbelt.

Umsatz und Prognose für den Markt für Transfektionsreagenzien und -geräte im asiatisch-pazifischen Raum bis 2030 (in Mio. USD)

Segmentierung des Marktes für Transfektionsreagenzien und -geräte im asiatisch-pazifischen Raum

Der Markt für Transfektionsreagenzien und -geräte im asiatisch-pazifischen Raum ist nach Produkt, Methode, Anwendung, Endbenutzer und Land segmentiert.

Basierend auf dem Produkt ist der Markt für Transfektionsreagenzien und -geräte im asiatisch-pazifischen Raum in Reagenzien und Instrumente unterteilt. Das Segment Reagenzien hatte 2022 einen größeren Anteil.

In Bezug auf die Methode ist der Markt für Transfektionsreagenzien und -geräte im asiatisch-pazifischen Raum in virale Methoden, nicht-virale Methoden und Hybridmethoden segmentiert. Das Segment nicht-virale Methoden hatte 2022 den größten Anteil. Das virale Segment ist in Retroviren, Adenoviren, Adeno-assoziierte Viren und Herpesviren unterteilt. Das nicht-virale Segment ist in physikalische/mechanische Methoden und chemische Methoden unterteilt. Darüber hinaus ist das Segment der physikalischen/mechanischen Methoden in Elektroporation, Mikroinjektion, biolistische Methode, Lasermethode, Magnetofektion und Sonoporation unterteilt. Auch das Segment der chemischen Methoden ist in liposomal/lipidreich und nicht liposomal/lipidreich unterteilt.

Nach Anwendung ist der Markt für Transfektionsreagenzien und -geräte im asiatisch-pazifischen Raum in biomedizinische Forschung, Proteinproduktion und Therapeutikaverabreichung unterteilt. Das Segment biomedizinische Forschung hatte 2022 den größten Anteil.

Basierend auf dem Endverbraucher ist der Markt für Transfektionsreagenzien und -geräte im asiatisch-pazifischen Raum in Hochschulen und Forschungsinstitute sowie Pharma- und Biotechnologieunternehmen unterteilt. Das Segment Hochschulen und Forschungsinstitute hatte 2022 einen größeren Anteil.

Nach Ländern ist der Markt für Transfektionsreagenzien und -geräte im asiatisch-pazifischen Raum in Australien, China, Indien, Japan, Südkorea und den Rest des asiatisch-pazifischen Raums unterteilt. China dominierte 2022 den Markt für Transfektionsreagenzien und -geräte im asiatisch-pazifischen Raum.

Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG, MaxCyte Inc und Polyplus-Transfection SA sind einige der führenden Unternehmen auf dem Markt für Transfektionsreagenzien und -geräte im asiatisch-pazifischen Raum.

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Transfection Reagents and Equipment Market - Key Market Dynamics

4.1 Asia Pacific Transfection Reagents and Equipment Market - Key Market Dynamics

4.2 Market Drivers

4.2.1 Increasing Popularity of Cell and Gene Therapy

4.2.2 Growing Economic Burden of Cancer

4.3 Market Restraints

4.3.1 High Cost of Instruments and Consumables

4.4 Market Opportunities

4.4.1 Ramping Up Small-Scale Processes to Large-Scale Processes

4.5 Future Trends

4.5.1 Strategic Initiatives by Companies

4.6 Impact of Drivers and Restraints:

5. Transfection Reagents and Equipment Market - Asia Pacific Market Analysis

5.1 Asia Pacific Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030

5.2 Asia Pacific Transfection Reagents and Equipment Market Forecast Analysis

6. Asia Pacific Transfection Reagents and Equipment Market Analysis - by Product

6.1 Reagents

6.1.1 Overview

6.1.2 Reagents: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

6.2 Equipment

6.2.1 Overview

6.2.2 Equipment: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Transfection Reagents and Equipment Market Analysis - by Modality

7.1 Viral

7.1.1 Overview

7.1.2 Viral: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.1.2.1 Retrovirus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.1.2.2 Adenovirus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.1.2.3 Adeno-Associated Virus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.1.2.4 Herpes Virus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2 Non-Viral

7.2.1 Overview

7.2.2 Non-Viral: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.1 Physical/Mechanical Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.1.1 Electroporation: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.1.2 Microinjection: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.1.3 Biolistic Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.1.4 Laser Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.1.5 Magnetofection: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.1.6 Sonoporation: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.2 Chemical Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.2.1 Liposomal Based/High Lipid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.2.2 Non-Liposomal Based/High Lipid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.3 Hybrid

7.3.1 Overview

7.3.2 Hybrid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Transfection Reagents and Equipment Market Analysis - by Application

8.1 Biomedical Research

8.1.1 Overview

8.1.2 Biomedical Research: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

8.2 Protein Production

8.2.1 Overview

8.2.2 Protein Production: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

8.3 Therapeutic Delivery

8.3.1 Overview

8.3.2 Therapeutic Delivery: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Transfection Reagents and Equipment Market Analysis - by End Users

9.1 Academic and Research Institutes

9.1.1 Overview

9.1.2 Academic and Research Institutes: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

9.2 Pharmaceutical and Biotechnological Companies

9.2.1 Overview

9.2.2 Pharmaceutical and Biotechnological Companies: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Transfection Reagents and Equipment Market -Country Analysis

10.1 Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country

10.1.1 Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country

10.1.1.1 China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 China: Transfection Reagents and Equipment Market Breakdown, by Product

10.1.1.1.2 China: Transfection Reagents and Equipment Market Breakdown, by Modality

10.1.1.1.2.1 China: Transfection Reagents and Equipment Market Breakdown, by Viral

10.1.1.1.2.2 China: Transfection Reagents and Equipment Market Breakdown, by Non-Viral

10.1.1.1.2.2.1 China: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method

10.1.1.1.2.2.2 China: Transfection Reagents and Equipment Market Breakdown, by Chemical Method

10.1.1.1.3 China: Transfection Reagents and Equipment Market Breakdown, by Application

10.1.1.1.4 China: Transfection Reagents and Equipment Market Breakdown, by End Users

10.1.1.2 Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Japan: Transfection Reagents and Equipment Market Breakdown, by Product

10.1.1.2.2 Japan: Transfection Reagents and Equipment Market Breakdown, by Modality

10.1.1.2.2.1 Japan: Transfection Reagents and Equipment Market Breakdown, by Viral

10.1.1.2.2.2 Japan: Transfection Reagents and Equipment Market Breakdown, by Non-Viral

10.1.1.2.2.2.1 Japan: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method

10.1.1.2.2.2.2 Japan: Transfection Reagents and Equipment Market Breakdown, by Chemical Method

10.1.1.2.3 Japan: Transfection Reagents and Equipment Market Breakdown, by Application

10.1.1.2.4 Japan: Transfection Reagents and Equipment Market Breakdown, by End Users

10.1.1.3 India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 India: Transfection Reagents and Equipment Market Breakdown, by Product

10.1.1.3.2 India: Transfection Reagents and Equipment Market Breakdown, by Modality

10.1.1.3.2.1 India: Transfection Reagents and Equipment Market Breakdown, by Viral

10.1.1.3.2.2 India: Transfection Reagents and Equipment Market Breakdown, by Non-Viral

10.1.1.3.2.2.1 India: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method

10.1.1.3.2.2.2 India: Transfection Reagents and Equipment Market Breakdown, by Chemical Method

10.1.1.3.3 India: Transfection Reagents and Equipment Market Breakdown, by Application

10.1.1.3.4 India: Transfection Reagents and Equipment Market Breakdown, by End Users

10.1.1.4 South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.1 South Korea: Transfection Reagents and Equipment Market Breakdown, by Product

10.1.1.4.2 South Korea: Transfection Reagents and Equipment Market Breakdown, by Modality

10.1.1.4.2.1 South Korea: Transfection Reagents and Equipment Market Breakdown, by Viral

10.1.1.4.2.2 South Korea: Transfection Reagents and Equipment Market Breakdown, by Non-Viral

10.1.1.4.2.2.1 South Korea: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method

10.1.1.4.2.2.2 South Korea: Transfection Reagents and Equipment Market Breakdown, by Chemical Method

10.1.1.4.3 South Korea: Transfection Reagents and Equipment Market Breakdown, by Application

10.1.1.4.4 South Korea: Transfection Reagents and Equipment Market Breakdown, by End Users

10.1.1.5 Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.1 Australia: Transfection Reagents and Equipment Market Breakdown, by Product

10.1.1.5.2 Australia: Transfection Reagents and Equipment Market Breakdown, by Modality

10.1.1.5.2.1 Australia: Transfection Reagents and Equipment Market Breakdown, by Viral

10.1.1.5.2.2 Australia: Transfection Reagents and Equipment Market Breakdown, by Non-Viral

10.1.1.5.2.2.1 Australia: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method

10.1.1.5.2.2.2 Australia: Transfection Reagents and Equipment Market Breakdown, by Chemical Method

10.1.1.5.3 Australia: Transfection Reagents and Equipment Market Breakdown, by Application

10.1.1.5.4 Australia: Transfection Reagents and Equipment Market Breakdown, by End Users

10.1.1.6 Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.1 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Product

10.1.1.6.2 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Modality

10.1.1.6.2.1 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Viral

10.1.1.6.2.2 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Non-Viral

10.1.1.6.2.2.1 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method

10.1.1.6.2.2.2 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Chemical Method

10.1.1.6.3 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Application

10.1.1.6.4 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by End Users

11. Transfection Reagents and Equipment Market -Industry Landscape

11.1 Overview

11.2 Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023

11.3 Inorganic Growth Strategies

11.3.1 Overview

11.4 Organic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 Thermo Fisher Scientific Inc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Promega Corp

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 F. Hoffmann-La Roche Ltd

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Bio-Rad Laboratories Inc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Mirus Bio LLC

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 QIAGEN NV

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Merck KGaA

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Lonza Group AG

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 MaxCyte Inc

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

13. Appendix

13.1 About Us

List of Tables

Table 1. Asia Pacific Transfection Reagents and Equipment Market Segmentation

Table 2. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Table 3. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Product

Table 4. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Modality

Table 5. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Viral

Table 6. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Non-Viral

Table 7. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Physical/mechanical Method

Table 8. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Chemical Method

Table 9. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 10. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by End Users

Table 11. Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Country

Table 12. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 13. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality

Table 14. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral

Table 15. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral

Table 16. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method

Table 17. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method

Table 18. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 19. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users

Table 20. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 21. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality

Table 22. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral

Table 23. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral

Table 24. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method

Table 25. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method

Table 26. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 27. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users

Table 28. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 29. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality

Table 30. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral

Table 31. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral

Table 32. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method

Table 33. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method

Table 34. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 35. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users

Table 36. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 37. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality

Table 38. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral

Table 39. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral

Table 40. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method

Table 41. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method

Table 42. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 43. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users

Table 44. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 45. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality

Table 46. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral

Table 47. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral

Table 48. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method

Table 49. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method

Table 50. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 51. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users

Table 52. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 53. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality

Table 54. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral

Table 55. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral

Table 56. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method

Table 57. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method

Table 58. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 59. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users

Table 60. Recent Inorganic Growth Strategies in the Transfection Reagents and Equipment Market

Table 61. Recent Organic Growth Strategies in The Transfection Reagents and Equipment Market

List of Figures

Figure 1. Asia Pacific Transfection Reagents and Equipment Market Segmentation, by Country

Figure 2. Impact Analysis of Drivers and Restraints

Figure 3. Asia Pacific Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030

Figure 4. Asia Pacific Transfection Reagents and Equipment Market Share (%) - by Product (2022 and 2030)

Figure 5. Reagents: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 6. Equipment: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Asia Pacific Transfection Reagents and Equipment Market Share (%) - by Modality (2022 and 2030)

Figure 8. Viral: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Retrovirus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Adenovirus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Adeno-Associated Virus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Herpes Virus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Non-Viral: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Physical/Mechanical: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Electroporation: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Microinjection: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Biolistic Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Laser Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Magnetofection: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Sonoporation: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Chemical Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Liposomal Based/High Lipid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. Non-Liposomal Based/High Lipid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 24. Hybrid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 25. Asia Pacific Transfection Reagents and Equipment Market Share (%) - by Application (2022 and 2030)

Figure 26. Biomedical Research: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 27. Protein Production: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 28. Therapeutic Delivery: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 29. Asia Pacific Transfection Reagents and Equipment Market Share (%) - by End Users (2022 and 2030)

Figure 30. Academic and Research Institutes: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 31. Pharmaceutical and Biotechnological Companies: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 32. Asia Pacific: Transfection Reagents and Equipment Market- Revenue by Key Countries 2022 (US$ Million)

Figure 33. Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 34. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)

Figure 35. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)

Figure 36. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)

Figure 37. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)

Figure 38. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)

Figure 39. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)

Figure 40. Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023

1. Thermo Fisher Scientific Inc
2. Promega Corp
3. F. Hoffmann-La Roche Ltd
4. Bio-Rad Laboratories Inc
5. Mirus Bio LLC
6. QIAGEN NV
7. Merck KGaA
8. Lonza Group AG
9. MaxCyte Inc
10. Polyplus-Transfection SA

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific transfection reagents and equipment market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific transfection reagents and equipment market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440